Clinical Trials Logo

Clinical Trial Summary

The primary objective of the study is to characterize seizures in participants with KCNT1-related epilepsy. The secondary objectives are to characterize head growth, symptom severity, neurocognitive and social functions, adaptive behavior, sleep, quality of life, caregiver burden, and mood in participants with KCNT1-related epilepsy.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04924153
Study type Observational
Source Biogen
Contact
Status Completed
Phase
Start date August 17, 2021
Completion date August 29, 2023